Introduction to Clinical Trials
This course provides core clinical trial knowledge on: GCP, monitoring, safety, auditing, registration, and study results publication.
Koniec kursu:
Opis kursu
The "Introduction to Clinical Trials" course is a comprehensive introduction to the world of medicinal product research. Designed for individuals interested in developing a career in clinical research, it provides both theoretical and practical knowledge related to planning, conducting, and evaluating clinical studies.
COURSE OBJECTIVES
- You will develop skills in designing and conducting clinical trials in accordance with current standards and regulations.
- You will master techniques for monitoring and reporting clinical trial progress, enabling effective control of research quality and compliance.
- You will learn how to collaborate efficiently with research teams and regulatory organizations, ensuring adherence to legal and ethical requirements.
- You will complete a project that allows you to apply clinical research knowledge in practice, considering participant diversity and the specifics of the medicinal product under investigation.
- You will gain knowledge of legal regulations, GCP principles, and the role of diversity in clinical trials, helping you approach challenges in new drug development professionally.
- You will acquire solid theoretical foundations and practical guidance that will support your growth in the dynamic field of clinical research.
TOPICS COVERED
MODULE 1 & 2
Fundamentals of Clinical Trials
In the first and second modules, you will learn about the basics of clinical trials, including trial phases, objectives, and their application in medicine.
MODULE 3
Clinical Trial Monitoring
In the third module, you will explore procedures for monitoring clinical trials, ensuring their quality and adherence to the study protocol.
MODULE 4
Audit and Inspections in Clinical Trials
In the fourth module, you will learn how to prepare for clinical trial audits and inspections, as well as how to ensure compliance with applicable regulations.
MODULE 5
Pharmacovigilance
In the fifth module, you will learn the principles of medicinal product safety, risk analysis, and procedures associated with pharmacovigilance.
MODULE 6
Ethics and Legal Aspects in Clinical Research
In the sixth module, you will explore ethical principles and legal regulations related to clinical trials, including Good Clinical Practice (GCP) standards.
MODULE 7
Clinical Trial Registration
In the seventh module, you will learn how clinical trials are registered and how to effectively publish results in the scientific community.
MODULE 8
Diversity in Clinical Research
In the eighth module, you will discover the importance of diversity in clinical trials and how inclusivity influences participant selection.
COURSE COMPLETION AND CERTIFICATION REQUIREMENTS
The course includes eight knowledge assessments, one for each module. Review all learning materials provided within the modules and achieve at least 60% on each test to pass the course and receive a certificate. You may attempt each test up to three times.
COURSE TEAM
Agata Wiesiołek
Executive Director at AstraZeneca, expert in global clinical trials
Patrycja Florczuk-Kołomyja
Associate Director and expert in local clinical trials at AstraZeneca
Olga Bogaczyńska
Director of Process Compliance at AstraZeneca, expert in audits and research oversight
Marek Rychter
Associate Director for Regulatory Affairs at AstraZeneca
Wiktor Krzymowski
Doctor of Law specializing in pharmaceutical law, attorney at AstraZeneca
Kamil Kuhr
Director of Research & Development Education at AstraZeneca, expert in diversity and education
Aleksandra Tyl-Płóciennik
Associate Director and expert in risk-based clinical quality management at AstraZeneca
Aleksander Dalewski
Senior Director for Study Management and Innovation at AstraZeneca, expert in global clinical trials
Andrzej Kinasiewicz
Director of Central Monitoring, expert in risk-based clinical quality management at AstraZeneca
Michał Chrzanowski
Associate Director for Compliance and Inspection Excellence, expert in pharmacotherapy safety monitoring at AstraZeneca
Alicja Ochmańska
Associate Director for Oncology Regulatory Affairs at AstraZeneca, expert in diversity

Anna Grudnicka
Senior Director for Clinical Portfolio Management, expert in oncology research
Natalia Łojko
Head of Legal Department at AstraZeneca